- Report
- January 2024
- 86 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
- Book
- March 2022
- 992 Pages
Warfarin is a cardiovascular drug used to prevent and treat blood clots. It is an anticoagulant, meaning it helps to prevent the formation of clots in the blood vessels. Warfarin is used to treat and prevent deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to reduce the risk of stroke in people with atrial fibrillation. Warfarin is available in both generic and brand-name forms.
The Warfarin market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include Pfizer, GlaxoSmithKline, Sanofi, Bristol-Myers Squibb, and Merck. Other companies include Teva Pharmaceuticals, Mylan, and Novartis. Show Less Read more